Key result
In an 88-year-old woman with a persisting retro-auricular hematoma, immunohistochemical analysis for MYC oncoprotein confirmed cutaneous angiosarcoma, which proved fatal despite palliative radiotherapy.
Why the study?
Cutaneous angiosarcoma is a rare and aggressive tumor whose timely diagnosis is critical but frequently delayed due to slow onset and variable presentation.
Case Report (n=1)
This case highlights the diagnostic challenges of cutaneous angiosarcoma, which can mimic benign lesions and requires immunohistochemical analysis for confirmation.
Indicates limited survival after palliative irradiation in advanced disease; leaves open optimal strategies pending larger studies.
Cutaneous angiosarcoma (cAS) is a rare and aggressive malignant vascular tumor, which mostly occurs in the head and neck region. The outcome of cAS is poor and timely diagnosis is paramount, but often delayed because of the slow onset and the variance in presentation. This paper reports on a case of an 88-year old woman who presented with a persisting "hematoma" in the left retro-auricular region. Although considered at initial differential diagnosis, no signs of malignancy were identified in histopathology and imaging in the diagnostic work-up. At first, short-term follow-up showed no progression of the lesion. But 3 months after the first presentation additional biopsies were taken, because of rapid expansion of the lesion. The initial histopathological findings were most consistent with a benign vascular lesion, with signs of hemorrhage and reactive inflammation. However, the additional immunohistochemical analysis showed the presence of MYC oncoprotein, which confirmed the clinical suspicion of angiosarcoma. Because size and location of the lesion rendered complete resection unattainable, radiotherapy was commenced, but no significant volume reduction could be achieved. Therefore, palliative irradiation was initiated. The patient passed away 1 month later. Clinical diagnosis is often difficult and little is known about imaging of cAS. Histology and immunohistochemistry can be misleading, as cAS are easily mistaken for other lesions. Most studies report that multimodality treatment with surgery and radiotherapy is preferable, but this can be challenging in the head & neck region.
No takes yet. Share an insight, caveat, or question.
Wilssens et al. (2020) conducted a case report in Cutaneous angiosarcoma (n=1). Radiotherapy was evaluated. In an 88-year-old woman with a persisting retro-auricular hematoma, immunohistochemical analysis for MYC oncoprotein confirmed cutaneous angiosarcoma, which proved fatal despite palliative radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: